J&J | L'Utile Ante Imposte



Pre Tax Profit Cambiamento Data
AbbVie USD 4.81B 1.54B 2024-12
Abbott USD 1.78B 252M 2025-03
Amgen USD 3.38B 111M 2024-12
AstraZeneca USD 3.4B 1.74B 2025-03
Baxter International USD -289000000 594M 2024-12
Bayer EUR 1.83B 2.31B 2025-03
Becton, Dickinson and Co. USD 306M 1.01B 2024-12
Biogen USD 572.2M 118.5M 2024-12
Boston Scientific USD 1.24B 79M 2025-03
Bristol-Myers Squibb USD 2.97B 1.29B 2025-03
CONMED USD 43.64M 3.69M 2024-12
Cooper Companies USD 153.3M 15.3M 2025-01
Dexcom USD 231.9M 5.1M 2024-12
Edwards Lifesciences USD 395.2M 42.7M 2024-12
Eli Lilly USD 3.46B 2.08B 2025-03
Gilead Sciences USD 2.96B 112M 2024-12
GlaxoSmithKline GBP 2.11B 1.55B 2025-03
Globus Medical USD 120.72M 23.97M 2024-12
Hologic USD 296.4M 600K 2024-12
Indivior 59M 29M 2025-03
Insulet USD 48.1M 63.2M 2025-03
Integra LifeSciences USD -18237000 98.27M 2024-12
Intuitive Surgical USD 668.5M 2.01B 2025-03
J&J USD 13.63B 8.21B 2025-03
Medtronic USD 1.54B 455M 2025-01
Merck USD 5.22B 114M 2024-12
Merit Medical Systems USD 37.96M 112.04M 2025-03
Novartis USD 4.66B 269M 2024-12
Pfizer USD 4.44B 2.36B 2024-12
Regeneron Pharmaceuticals USD 905M 53.1M 2025-03
Roche Holding CHF 1.78B 2.33B 2024-12
Sanofi EUR 2.16B 20M 2025-03
Stryker USD 1.64B 376M 2024-12
Tandem Diabetes Care USD -122089000 30.22M 2025-03
Teva Pharmaceutical Industries USD 294M 605M 2025-03
Vertex Pharmaceuticals USD 1.32B 109.7M 2024-12
Zimmer Biomet Holdings USD 289M 104.4M 2024-12
Zoetis USD 773M 144M 2024-12



J&J L'Utile Ante Imposte - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.